article thumbnail

Use of Artificial Intelligence in Healthcare Industry in Mainland China

Triage Health Law

Since 2016, China has issued a series of relevant policies, including the “Internet+” Artificial Intelligence Three-Year Action and Implementation Plan, Guiding Opinions on Promoting and Regulating the Application and Development of Big Data in Health and Medical Care and the “Healthy China 2030” Blueprint.

article thumbnail

How Intelligent Document Processing (IDP) Revolutionizes Clinical Trials

HIT Consultant

It is because of these two challenges that the pharmaceutical industry has been cautious about integrating generative AI into regulated and sensitive data workflows, which in turn has slowed down adoption. This will speed up data collection and quality control processes.